Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
$37.40
-8.4%
Analyst Price Target
$33.50
-18%
Metric TTM (2025-03 – 2025-12)
Operating Cash Flow $45.33M
Capital Expenditure $0.00
Free Cash Flow $45.33M

People Also View

MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 RXDX
RXDX
Prometheus Biosciences, Inc.
$199.92
+0.09%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
 IMVT
IMVT
Immunovant, Inc.
$26.55
+5.69%
 TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
 AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
 MRTX
MRTX
Mirati Therapeutics, Inc.
$58.70
-0.17%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message